prednisolone hemisuccinate
PolandDrugs containing this active substance
-
The medicine is used in many serious conditions, such as: anaphylactic shock, pulmonary edema (e.g., after inhaling toxins or drowning), severe asthma attack, cerebral edema, risk of organ transplant rejection, acute skin diseases, acute blood diseases, post-infarction syndrome, severe infectious diseases, adrenal cortex insufficiency, and pseudocroup.
Form: solution for injection / infusion, powder and solvent for preparation of
Active substance Dosage prednisolone hemisuccinate 50 mg ATC: H02AB06
Manufacturer: mibe GmbH Pharmaceuticals
-
The medicinal product is used in many serious conditions, such as: anaphylactic shock, pulmonary edema (e.g., after inhaling toxins or drowning), severe asthma attack, cerebral edema, risk of organ transplant rejection, acute skin and blood diseases, post-infarction syndrome, severe infectious diseases, adrenal insufficiency, and pseudocroup.
Form: solution for injection / infusion, powder and solvent for preparation of
Active substance Dosage prednisolone hemisuccinate 25 mg ATC: H02AB06
Manufacturer: mibe GmbH Pharmaceuticals
-
The medicine is used in many serious conditions, such as: anaphylactic shock, pulmonary edema (e.g., after inhaling toxins or drowning), severe asthma attack, cerebral edema, risk of organ transplant rejection, severe skin diseases, acute blood diseases, post-infarction syndrome, severe infectious diseases, adrenal cortex insufficiency, and pseudocroup.
Form: solution for injection / infusion, powder and solvent for preparation of
Active substance Dosage prednisolone hemisuccinate 250 mg ATC: H02AB06
Manufacturer: mibe GmbH Pharmaceuticals
-
The medicine is used in many serious conditions, such as: anaphylactic shock, pulmonary edema (e.g., after inhaling toxins or drowning), severe asthma attack, cerebral edema, risk of kidney transplant rejection, severe skin diseases, acute blood disorders, post-infarction syndrome, certain severe infectious diseases, adrenal cortex insufficiency, and pseudocroup.
Form: solution for injection / infusion, powder and solvent for preparation of
Active substance Dosage prednisolone hemisuccinate 1000 mg ATC: H02AB06
Manufacturer: mibe GmbH Pharmaceuticals